In individuals with kidney disease, epoetin alfa is used to treat severe anemia. Bone or joint pain, weakness, heartburn, stomach ache, etc. are some of its negative effects.
Human erythropoietin epoetin alfa is created in cell culture utilizing recombinant DNA technology. On August 28, 2007, the European Medicines Agency approved it for use. It increases erythropoiesis and is used to treat anemia, which is frequently brought on by chemotherapy for cancer and chronic kidney failure.
Products containing epoetin alfa belong to the group of drugs known as erythropoiesis-stimulating agents (ESAs). They function by increasing the production of red blood cells in the bone marrow, which is a soft substance found inside the bones.
While you are using this medication, it is crucial that your doctor perform routine blood tests on you or your kid.
To learn more about epoetin from the given link:
brainly.com/question/28540728
#SPJ4
